Pfizer Korea takes legal suit against price cut

Reportedly, Pfizer Korea lodged its administrative suit, via Kim& Chang law and patent office on September 30, against the government's price cut of insurance-covered drugs based on the previous actually transacted minimum price system.

Business sources say that Pfizer Korea has been the main victim from the government's price decision this time and other multinational firms stationed in K...